FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
CARDIZEM
diltiazem hydrochloride
LOE Approaching
INJECTION · INJECTABLE
hypertensionchronic stable angina+1
1997
NDA30/100
CARDIZEM
diltiazem hydrochloride
LOE Approaching
Bausch + Lomb
ORAL · TABLET
chronic stable anginaangina due to coronary artery spasm
1982
NDA30/100
CARDIZEM
diltiazem hydrochloride
LOE Approaching
INJECTION · INJECTABLE
hypertensionchronic stable angina+1
1991
NDA30/100
CARDIZEM CD
diltiazem hydrochloride
LOE Approaching
Bausch + Lomb
ORAL · CAPSULE, EXTENDED RELEASE
hypertensionchronic stable angina+1
1991
NDA30/100
CARDIZEM LA
diltiazem hydrochloride
LOE Approaching
Bausch + Lomb
ORAL · TABLET, EXTENDED RELEASE
hypertensionto lower blood pressure+2
2003
NDA30/100
CARDIZEM SR
diltiazem hydrochloride
LOE Approaching
ORAL · CAPSULE, EXTENDED RELEASE
hypertensionchronic stable angina+1
1989
NDA30/100
CARDURA
doxazosin
LOE Approaching
Viatris (2)
ORAL · TABLET
the signssymptoms of BPH+4
1990
NDA30/100
CARDURA XL
doxazosin mesylate
LOE Approaching
Viatris (2)
ORAL · TABLET, EXTENDED RELEASE
hypertensionthe signs+1
2005
NDA30/100
CARNITOR
levocarnitine
LOE Approaching
Leadiant Biosciences
ORAL · SOLUTION
the treatment of primary systemic carnitine deficiency
1985
NDA30/100
CARNITOR
levocarnitine
LOE Approaching
Leadiant Biosciences
INJECTION · INJECTABLE
1992
NDA30/100
CARNITOR
levocarnitine
LOE Approaching
Leadiant Biosciences
ORAL · SOLUTION
the treatment of primary systemic carnitine deficiency
1986
NDA30/100
CARNITOR SF
levocarnitine
LOE Approaching
Leadiant Biosciences
ORAL · SOLUTION
the treatment of primary systemic carnitine deficiency
1986
NDA30/100
CARTROL
carteolol hydrochloride
LOE Approaching
AbbVie
ORAL · TABLET
hypertensionglaucoma
1988
NDA30/100
CASODEX
bicalutamide
LOE Approaching
ANI Pharmaceuticals
ORAL · TABLET
1995
NDA30/100
CASODEX
bicalutamide
LOE Approaching
AstraZeneca
ORAL · TABLET
2008
NDA30/100
CASPORYN HC
neomycin and polymyxin b sulfates and hydrocortisone otic
LOE Approaching
R-Pharm US
OTIC · SUSPENSION/DROPS
1975
NDA30/100
CATAFLAM
diclofenac potassium
LOE Approaching
Novartis
ORAL · TABLET
migraine
1993
NDA30/100
CATAPRES
clonidine hydrochloride
LOE Approaching
Boehringer Ingelheim
ORAL · TABLET
the treatment of hypertensionhypertension
1974
NDA30/100
CATAPRES-TTS-1
clonidine transdermal system
LOE Approaching
Lavipharm
TRANSDERMAL · SYSTEM
the treatment of hypertensionhypertension
1984
NDA30/100
CATAPRES-TTS-2
clonidine transdermal system
LOE Approaching
Lavipharm
TRANSDERMAL · SYSTEM
the treatment of hypertensionhypertension
1984
NDA30/100
CATAPRES-TTS-3
clonidine transdermal system
LOE Approaching
Lavipharm
TRANSDERMAL · SYSTEM
the treatment of hypertensionhypertension
1984
NDA30/100
CAVERJECT
alprostadil
LOE Approaching
Pfizer
INJECTION · INJECTABLE
erectile dysfunction
1997
NDA30/100
CAVERJECT
alprostadil
LOE Approaching
Pfizer
INJECTION · INJECTABLE
erectile dysfunction
1995
NDA30/100
CAVERJECT IMPULSE
alprostadil
LOE Approaching
Pfizer
INJECTION · INJECTABLE
erectile dysfunction
2002
NDA30/100